Key facts
- Northernmost’s last known valuation is $5.0M (Apr 2025).
- It has raised $1.9M; the latest was Early Stage VC in Apr 2026.
- Notable investors include Creative Destruction Lab, Accelerate Fund, Edmonton Unlimited, Innovobot, Leva Capital — 9 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for Northernmost
- ·The full record, as it builds
Funding rounds
No funding rounds for Northernmost are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Northernmost
Developer of a perfusion machine designed to preserve and transport organs for transplant. The company aims to advance machine preservation technology and logistics, eliminate static storage coolers, increase the utilization of donor organs, and improve transplant outcomes, enabling healthcare professionals to improve transplant outcomes by saving costs.
- Sector
- Healthcare
- HQ
- Edmonton, Canada
- Founded
- 2022
- Employees
- 3
- Website
- northernmost.ca/
- Ownership
- Privately Held (backing)
Northernmost doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Northernmost shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Northernmost in its N-PORT filings yet. We sweep new filings monthly.